HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zheng-Rong Lu Selected Research

PAMAM-G6-cystamine-(Gd-DO3A)

9/2007In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zheng-Rong Lu Research Topics

Disease

75Neoplasms (Cancer)
10/2022 - 04/2002
17Breast Neoplasms (Breast Cancer)
01/2020 - 04/2002
11Prostatic Neoplasms (Prostate Cancer)
01/2020 - 04/2012
9Neoplasm Metastasis (Metastasis)
01/2022 - 01/2015
6Triple Negative Breast Neoplasms
08/2021 - 06/2015
6Retinal Degeneration
01/2021 - 01/2014
5Glioma (Gliomas)
11/2020 - 05/2009
5Colonic Neoplasms (Colon Cancer)
01/2016 - 04/2002
4Stargardt Disease
10/2021 - 12/2014
4Glioblastoma (Glioblastoma Multiforme)
11/2020 - 04/2013
4Hemolysis
01/2019 - 11/2007
3Hypoxia (Hypoxemia)
01/2016 - 02/2015
3Brain Neoplasms (Brain Tumor)
01/2015 - 04/2013
3Carcinoma (Carcinomatosis)
12/2008 - 01/2002
2Adenocarcinoma
01/2022 - 01/2019
2Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2019
2Eye Diseases (Eye Disease)
06/2017 - 12/2011
2Macular Degeneration (Age-Related Maculopathy)
03/2015 - 12/2014
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2022
1Inborn Genetic Diseases (Disease, Hereditary)
10/2021
1Retinal Dystrophies
01/2021
1Mouth Neoplasms (Oral Cancer)
12/2020
1Ataxia Telangiectasia (Louis Bar Syndrome)
11/2020
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Blindness (Hysterical Blindness)
06/2017

Drug/Important Bio-Agent (IBA)

47Contrast MediaIBA
10/2022 - 01/2006
25Fibronectins (Fibronectin)IBA
10/2022 - 12/2008
23Peptides (Polypeptides)IBA
01/2021 - 12/2008
14Small Interfering RNA (siRNA)IBA
07/2022 - 05/2009
11GadoliniumIBA
10/2022 - 01/2006
10Pharmaceutical PreparationsIBA
01/2020 - 04/2002
10FibrinIBA
08/2015 - 12/2008
9Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2010
9cyclo(cysteinyl- glycyl- leucyl- isoleucyl- isoleucyl- glutaminyl- lysyl- asparaginyl- glutamyl- cysteinyl)IBA
06/2014 - 12/2008
8LipidsIBA
01/2021 - 11/2013
7Oncogene Proteins (Oncogene Protein)IBA
01/2020 - 01/2017
6Proteins (Proteins, Gene)FDA Link
11/2020 - 08/2012
6gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
11/2017 - 03/2010
5Retinaldehyde (Retinal)IBA
10/2021 - 12/2014
5PolymersIBA
01/2018 - 09/2006
5CystamineIBA
02/2010 - 04/2005
5Gadolinium DTPA (Magnevist)FDA Link
02/2010 - 04/2005
4retinylamineIBA
01/2021 - 12/2014
4gadodiamide (Omniscan)FDA Link
01/2011 - 04/2005
4hydroxypropyl methacrylateIBA
06/2007 - 01/2002
3ManganeseIBA
07/2015 - 08/2010
3Surface-Active Agents (Surfactants)IBA
02/2015 - 11/2007
3Blood Proteins (Serum Proteins)IBA
08/2014 - 08/2012
3Glutamic Acid (Glutamate)FDA Link
09/2008 - 09/2006
2Long Noncoding RNAIBA
07/2022 - 01/2019
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2021 - 12/2014
2gadoteridol (Prohance)FDA Link
12/2020 - 10/2013
2Biological ProductsIBA
01/2020 - 12/2014
2Eukaryotic Initiation Factor-4EIBA
01/2020 - 11/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 06/2017
2gadofullereneIBA
01/2018 - 01/2017
2LigandsIBA
01/2017 - 04/2016
2Tumor Biomarkers (Tumor Markers)IBA
01/2017 - 06/2014
2oncofetal fibronectinIBA
01/2017 - 08/2010
2IntegrinsIBA
04/2016 - 06/2015
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2016 - 08/2010
2Transcription Factors (Transcription Factor)IBA
09/2015 - 02/2015
2cysteinyl-arginyl-glutamyl-lysyl-alanylIBA
08/2015 - 10/2013
2Fluorescent Dyes (Fluorescent Probes)IBA
05/2015 - 04/2013
2LuciferasesIBA
08/2014 - 11/2013
2Cystine (L-Cystine)IBA
09/2009 - 05/2009
2Photosensitizing Agents (Photosensitizers)IBA
09/2008 - 10/2006
2N-(2-hydroxypropyl)methacrylamideIBA
02/2007 - 04/2002
1Untranslated RNA (Noncoding RNA)IBA
07/2022
1Messenger RNA (mRNA)IBA
01/2022
1Nucleic AcidsIBA
10/2021
1RetinoidsIBA
01/2021
1Valine (L-Valine)FDA Link
01/2021
1Lipid NanoparticlesIBA
01/2021
1Amino AcidsFDA Link
01/2021
1Discoidin Domain ReceptorsIBA
11/2020
1DNA-Activated Protein KinaseIBA
11/2020
1propionamideIBA
11/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Dextrans (Dextran)FDA Link
01/2019
1Extracellular Matrix ProteinsIBA
01/2019
1cyclic arginine-glycine-aspartic acid peptideIBA
01/2019
1Radioisotopes (Radionuclides)IBA
01/2018
1Liposomes (Liposome)IBA
01/2018
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2018
1gamma-Aminobutyric Acid (GABA)IBA
01/2018
1Tiagabine (Gabitril)FDA Link
01/2018
1MicellesIBA
01/2018
1VigabatrinFDA Link
01/2018
1Immunoconjugates (Immunoconjugate)IBA
01/2018
1IgKIBA
11/2017
1CytokinesIBA
01/2017

Therapy/Procedure

27Therapeutics
07/2022 - 10/2007
5Intravenous Injections
11/2016 - 05/2009
4Drug Therapy (Chemotherapy)
01/2017 - 10/2006
2Injections
01/2018 - 02/2015
2Lasers (Laser)
08/2009 - 09/2008
2Photochemotherapy (Photodynamic Therapy)
09/2008 - 10/2006
1Radiotherapy
11/2020
1Precision Medicine
09/2017